These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37644794)

  • 1. Advancement in Polymer-based Carrier for DNA Vaccine.
    Goyal P; Malviya R
    Curr Pharm Des; 2023; 29(26):2062-2077. PubMed ID: 37644794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of DNA vaccines: current progress.
    Ferraro B; Morrow MP; Hutnick NA; Shin TH; Lucke CE; Weiner DB
    Clin Infect Dis; 2011 Aug; 53(3):296-302. PubMed ID: 21765081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to improve the immunogenicity of plasmid DNA vaccines.
    Eusébio D; Neves AR; Costa D; Biswas S; Alves G; Cui Z; Sousa Â
    Drug Discov Today; 2021 Nov; 26(11):2575-2592. PubMed ID: 34214667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants.
    Kim JJ; Yang JS; Manson KH; Weiner DB
    Vaccine; 2001 Mar; 19(17-19):2496-505. PubMed ID: 11257383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z; Mumper RJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):103-37. PubMed ID: 14584521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Immune Responses by Guanosine-Based Particles in DNA Plasmid Formulations against Infectious Diseases.
    Santos S; Ramírez M; Miranda E; Reyes N; Martínez O; Acosta-Santiago M; Rivera JM; Otero M
    J Immunol Res; 2019; 2019():3409371. PubMed ID: 31240233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.
    Suschak JJ; Williams JA; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2837-2848. PubMed ID: 28604157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines.
    Montgomery DL; Ulmer JB; Donnelly JJ; Liu MA
    Pharmacol Ther; 1997; 74(2):195-205. PubMed ID: 9336022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavivirus DNA Vaccine Design and Adjuvant Selection.
    Li L; Honda-Okubo Y; Petrovsky N
    Methods Mol Biol; 2021; 2183():405-422. PubMed ID: 32959256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines for targeting bacterial infections.
    Ingolotti M; Kawalekar O; Shedlock DJ; Muthumani K; Weiner DB
    Expert Rev Vaccines; 2010 Jul; 9(7):747-63. PubMed ID: 20624048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination.
    Ni J; Schirrmacher V; Fournier P
    Vaccine; 2010 Oct; 28(42):6891-900. PubMed ID: 20709006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.
    Bellier B; Dalba C; Clerc B; Desjardins D; Drury R; Cosset FL; Collins M; Klatzmann D
    Vaccine; 2006 Mar; 24(14):2643-55. PubMed ID: 16481074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
    Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
    Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.
    Karlsson I; Borggren M; Nielsen J; Christensen D; Williams J; Fomsgaard A
    Hum Vaccin Immunother; 2017 Aug; 13(8):1823-1830. PubMed ID: 28613978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Adjuvants for DNA Vaccines: Application, Design, Preparation, and Formulation.
    Sabbaghi A; Ghaemi A
    Methods Mol Biol; 2021; 2197():87-112. PubMed ID: 32827133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.